Statins may provide a new weapon to slow the progression of multiple sclerosis (MS). In a two-year trial, the drug simvastatin slowed brain shrinkage.
Patients on simvastatin achieved better scores on movement tests and questionnaires that assess disability than patients taking a placebo. The authors of the study, led by Imperial College London, said the findings were very encouraging, but would need to be replicated in a larger trial.
MMM has been operating worldwide as one of the leading system providers in the service of health since 1954. With a full portfolio of products and services pertaining to sterilization & disinfection systems for hospitals, scientific institutes, laboratories & the pharmaceutical industry, MMM has positioned itself as a crucial quality driver.
Hilton Birmingham Metropole Hotel
26th - 27th November 2024
Birmingham Conference & Events Centre (BCEC)
Wednesday 4th December 2024
TBA, Leeds
7th December 2024
Kia Oval, London
11th March 2025, 9:00am - 4:00pm
The National Conference Centre, Birmingham
29th – 30th April 2025
The National Conference Centre, Birmingham
11th April 2025
